This analysis examined the impact of the TRIPs agreement on the trade of pharmaceutical products between India and the UK, using data on exports and imports. The results showed that while exports increased by $63.85 million and imports increased by $16.24 million after the implementation of the agreement, these changes were not statistically significant. This suggests that the TRIPs agreement did not have a significant impact on the trade of pharmaceutical products between the two countries. Furthermore, the H-O model was applied to the trade relationship between India and the UK, revealing that India exports more generic drugs than it imports, as it is a labor-abundant country with a comparative advantage in this area. Conversely, India imports new innovative drugs from the UK, which are not as widely used as generic drugs. These findings suggest that the H-O model holds in the trade relationship between India and the UK. Additionally, GDP as a measure of well-being remained consistent before and after the TRIPS agreement.

This empirical analysis investigates the impact of welfare programs, specifically the

Supplemental Nutrition Assistance Program (SNAP) and Temporary Assistance for

Needy Families (TANF), on poverty rates in the United States. Using regression

discontinuity design (RDD), the study aims to discern the causal effects of SNAP on

poverty reduction and productivity enhancement. While the analysis offers insightful

findings, the results remain inconclusive. Although there is suggestive evidence of a

potential decrease in poverty rates following the introduction of SNAP, statistical

significance is lacking. Moreover, the low explanatory power of the model suggests

that factors beyond SNAP participation may influence poverty rates. Despite these

challenges, the study contributes to the ongoing discourse surrounding welfare

programs and poverty alleviation strategies, underscoring the complexity of assessing

their impact and highlighting the need for further research.